Differential expression of cytochrome P450 genes between bromadiolone-resistant and anticoagulant-susceptible Norway rats: A possible role for pharmacokinetics in bromadiolone resistance

Pest Management Science

Volumn 64, Issue 3, 2008, Pages 239-248

  Markussen, Mette D K ^a   Heiberg, Ann Charlotte ^a   Fredholm, Merete ^b   Kristensen, Michael ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Anticoagulant resistance; Bromadiolone; Cytochrome P450; Pharmacokinetics; Rattus norvegicus

Indexed keywords

CHEMICAL COMPOUND; COMPARATIVE STUDY; CYTOCHROME; GENE EXPRESSION; METABOLISM; MUTATION; PESTICIDE RESISTANCE; PROTEIN; RODENT;

RATTUS; RATTUS NORVEGICUS;

EID: 39749157587     PISSN: 1526498X     EISSN: 15264998     Source Type: Journal    
DOI: 10.1002/ps.1506     Document Type: Article

References (58)

1. 1 Bell RG and Caldwell PT, Mechanism of warfarin‐resistance. Warfarin and the metabolism of vitamin K 1. Biochemistry 12: 1759–1762 (1973).
2. 2 Whitlon DS, Sadowski JA and Suttie JW, Mechanism of coumarin action: significance of vitamin K epoxide reductase inhibition. Biochemistry 17: 1371–1377 (1978).
3. 3 Leck JB and Park BK, A comparative study of the effects of warfarin and brodifacoum on the relationship between vitamin K 1 metabolism and clotting factor activity in warfarin‐susceptible and warfarin‐resistant rats. Biochem Pharmacol 30: 123–128 (1981).
4. 4 Björk I and Stenflo J, A conformational study of normal and dicoumarol‐induced prothrombin. FEBS Lett 32: 343–346 (1973).
5. 5 Boyle CM, Case of apparent resistance of Rattus norvegicus Berkenhout to anticoagulant poisons. Nature (London) 188: 517 (1960).
6. 6 Lund M, Resistance to warfarin in the common rat. Nature (London) 203: 778 (1964).
7. 7 Drummond DC and Bentley EW, The resistance of rodents to warfarin in England and Wales, in EPPO Report of the International Conference on Rodents and Rodenticides, Paris 1965. EPPO Publications, Paris, pp. 56–67 (1967).
8. 8 Pelz H‐J, Hänisch D and Lauenstein G, Resistance to anticoagulant rodenticides in Germany and future strategies to control Rattus norvegicus. Pestic Sci 43: 61–67 (1995).
9. 9 Kerins GM, Dennis N, Atterby H, Gill JE and MacNicoll AD, Distribution of resistance to anticoagulant rodenticides in the Norway rat (Rattus norvegicus Berk.) in England 1995–98, in Advances in Vertebrate Pest Management II, ed. by Pelz H‐J, Cowan DP and Feare CJ. Filander‐Verlag, Fürth, Germany, pp. 149–159 (2001).
10. 10 Lodal J, Distribution and levels of anticoagulant resistance in rats (Rattus norvegicus) in Denmark, in Advances in Vertebrate Pest Management II, ed. by Pelz H‐J, Cowan DP and Feare CJ. Filander‐Verlag, Fürth, Germany, pp. 139–148 (2001).
11. 11 Pelz H‐J, Extensive distribution and high frequency of resistance to anticoagulant rodenticides in rat populations from Northwestern Germany, in Advances in Vertebrate Pest Management II, ed. by Pelz H‐J, Cowan DP and Feare CJ. Filander‐Verlag, Fürth, Germany, pp. 161–170 (2001).
12. 12 Greaves JH and Ayres P, Heritable resistance to warfarin in rats. Nature (London) 215: 877–878 (1967).
13. 13 Zimmermann A and Matschiner JT, Biochemical basis of hereditary resistance to warfarin in the rat. Biochem Pharmacol 23: 1033–1040 (1974).
14. 14 MacNicoll AD, A comparison of warfarin‐resistance and liver microsomal vitamin K epoxide reductase activity in rats. Biochim Biophys Acta 840: 13–20 (1985).
15. 15 Thijssen HHW, Warfarin inhibition of vitamin K epoxide reductase of Scottish resistant rats is reversible, in 17th Steenbock Symp., Current Advances in Vitamin K Research, ed. by Suttie JW. Elsevier Science Publ. Co., New York, NY, pp. 429–434 (1988).
16. 16 Rost S, Fregin A, Ivaskevicius V, Conzelmann E, Hörtnagel K, Pelz H‐J, et al, Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature (London) 427: 537–541 (2004).
17. 17 Li T, Chang C‐Y, Jin D‐Y, Lin P‐J, Khvorova A and Stafford DW, Identification of the gene for vitamin K epoxide reductase. Nature (London) 427: 541–544 (2004).
18. 18 Pelz H‐J, Rost S, Hünerberg M, Fregin A, Heiberg A‐C, Baert K, et al, The genetic basis of resistance to anticoagulants in rodents. Genetics 170: 1839–1847 (2005).
19. 19 Greaves JH and Cullen‐Ayres PB, Genetics of difenacoum resistance in the rat, in 17th Steenbock Symp., Current Advances in Vitamin K Research, ed. by Suttie JW. Elsevier Science Publ. Co., New York, NY, pp. 389–397 (1988).
20. 20 Bachmann KA and Sullivan TJ, Dispositional and pharmacodynamic characteristics of brodifacoum in warfarin‐sensitive rats. Pharmacol 27: 281–288 (1983).
21. 21 Thijssen HHW, Warfarin based rodenticides: mode of action and mechanism of resistance. Pestic Sci 43: 73–78 (1995).
22. 22 Degtyarenko KN and Archakov AI, Molecular evolution of P450 superfamily and P450‐containing monooxygenase systems. FEBS Lett 332: 1–8 (1993).
23. 23 Kaminsky LS and Zhang Z‐Y, Human P450 metabolism of warfarin. Pharmacol Ther 73: 67–74 (1997).
24. 24 Kaminsky LS, Guengerich FP, Dannan GA and Aust SD, Comparisons of warfarin metabolism by liver microsomes of rats treated with a series of polybrominated biphenyl congeners and by the component‐purified cytochrome P‐450 isozymes. Arch Biochem Biophys 225: 398–404 (1983).
25. 25 Kaminsky LS, Fasco MJ and Guengerich FP, Comparison of different forms of purified cytochrome P‐450 from rat liver by immunological inhibition of regio‐ and stereoselective metabolism of warfarin. J Biol Chem 255: 85–91 (1980).
26. 26 Guengerich FP, Dannan GA, Wright ST, Martin MV and Kaminsky LS, Purification and characterization of liver microsomal cytochromes P‐450: electrophoretic, spectral, catalytic and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital and beta‐naphtoflavone. Biochemistry 21: 6019–6030 (1982).
27. 27 Ishizuka M, Okajima F, Tanikawa T, Min H, Tanaka KD, Sakamoto KQ, et al, Elevated warfarin metabolism in warfarin‐resistant roof rats (Rattus rattus) in Tokyo. Drug Metab Dispos 35: 62–66. (2007).
28. 28 Pool JG, O'Reilly RA, Schneiderman LJ and Alexander M, Warfarin resistance in the rat. Am J Physiol 215: 627–631 (1968).
29. 29 Hermodson MA, Suttie JW and Link KP, Warfarin metabolism and vitamin K requirement in the warfarin resistant rat. Am J Physiol 217: 1316–1319 (1969).
30. 30 Townsend MG, Odam EM and Page JMJ, Studies on the microsomal drug metabolism system in warfarin‐resistant and ‐susceptible rats. Biochem Pharmacol 24: 729–735 (1975).
31. 31 Atterby H, Kelly MJ and MacNicoll AD, Difenacoum resistance in rats is not a consequence of increased metabolism and excretion, in Advances in Vertebrate Pest Management II, ed. by Pelz H‐J, Cowan DP and Feare CJ. Filander‐Verlag, Fürth, Germany, pp. 193–201 (2001).
32. 32 Markussen MD, Heiberg A‐C, Alsbo C, Nielsen PS, Kauppinen S and Kristensen M, Involvement of hepatic xenobiotic related genes in bromadiolone resistance in wild Norway rats, Rattus norvegicus (Berk.). Pest Biochem Physiol 88: 284–295 (2007).
33. 33 Skett P, Hormonal regulation and sex differences of xenobiotic metabolism. Prog Drug Metab 10: 85–139 (1987).
34. 34 Waxman DJ, Interactions of hepatic cytochromes P‐450 with steroid hormones: regioselectivity and stereospecificity of steroid metabolism and hormonal regulation of rat P‐450 enzyme expression. Biochem Pharmacol 37: 71–84 (1988).
35. 35 Waxman DJ, Ram PA, Park S‐H and Choi HK, Intermittent plasma growth hormone triggers tyrosine phophorylation and nuclear translocation of a liver‐expressed, Stat 5‐related DNA binding protein. Proposed role as an intracellular regulator of male‐specific liver gene transcription. J Biol Chem 270: 13262–13270 (1995).
36. 36 Kedderis GL and Mugford CA, Sex‐dependent metabolism of xenobiotics. Drug Metab Rev 30: 441–498 (1998).
37. 37 Zhu X and Shin WG, Gender differences in pharmacokinetics of oral warfarin in rats. Biopharm Drug Dispos 26: 147–150 (2005).
38. 38 Legraverend C, Mode A, Wells T, Robinson I and Gustafsson JA, Hepatic steroid hydroxylating enzymes are controlled by the sexually dimorphic pattern of growth hormone secretion in normal dwarf rats. FASEB J 6: 711–718 (1992).
39. 39 Gill JE, Kerins GM, Langton SD and MacNicoll AD, Blood‐clotting response test for bromadiolone resistance in Norway rats. J Wildlife Manag 58: 454–461 (1994).
40. 40 Kohn MH and Pelz H‐J, Genomic assignment of the warfarin resistance locus, Rw, in the rat. Mammal Genome 10: 696–698 (1999).
41. 41 Thomas PE, Reik LM, Ryan DE and Levin W, Regulation of three forms of cytochrome P‐450 and epoxide hydrolase in rat liver microsomes: effects of age, sex and induction. J Biol Chem 256: 1044–1052 (1981).
42. 42 Arlotto MP and Parkinson A, Identification of cytochrome P450a (P450IIA1) as the principal testosterone 7‐alpha‐hydroxylase in rat liver microsomes and its regulation by thyroid hormones. Arch Biochem Biophys 270: 458–471 (1989).
43. 43 Kamataki T, Maeda K, Yamazoe Y, Nagai T and Kato R, Sex difference of cytochrome P‐450 in the rat: purification, characterization and quantitation of constitutive forms of cytochrome P‐450 from liver microsomes of male and female rats. Arch Biochem Biophys 225: 758–770 (1983).
44. 44 MacGeoch C, Morgan ET, Halpert J and Gustafsson JA, Purification, characterization and pituitary regulation of the sex‐specific cytochrome P‐450 15‐beta‐hydroxylase from liver microsomes of untreated female rats. J Biol Chem 259: 15433–15439 (1984).
45. 45 McClellan‐Green PD, Linko P, Yeowell HN and Goldstein JA, Hormonal regulation of male‐specific rat hepatic cytochrome P‐450g (P‐450IIC13) by androgens and the pituitary. J Biol Chem 264: 18960–18965 (1989).
46. 46 Ahluwalia A, Clodfelter KH and Waxman DJ, Sexual dimorphism of rat liver gene expression: regulatory role of growth hormone revealed by deoxyribonucleic acid microarray analysis. Mol Endocrin 18: 747–760 (2004).
47. 47 Wright MC, Edwards RJ, Pimenta M, Ribeiro V, Ratra GS, Lechner MC, et al, Developmental changes in the constitutive and inducible expression of cytochrome P450 3A2. Biochem Pharmacol 54: 841–846 (1997).
48. 48 Kamataki T, Maeda K, Shimada M, Kitani K, Nagai T and Kato R, Age‐related alteration in the activities of drug‐metabolizing enzymes and contents of sex‐specific forms of cytochrome P‐450 in liver microsomes from male and female rats. J Pharmacol Exp Ther 223: 222–228 (1985).
49. 49 Imaoka S, Fujita S and Funae Y, Age‐dependent expression of cytochrome P‐450s in rat liver. Biochem Biophys Acta 1097: 187–192 (1991).
50. 50 Heiberg A‐C, Leirs H and Siegismund HR, Bromadiolone resistance does not respond to absence of anticoagulants in experimental populations, in Rats, Mice and People: Rodent Biology and Management, ed. by Singleton GR, Hinds LA, Krebs CJ and Spratt DM. Australian Centre for International Agricultural Research (ACIAR), Canberra, Australia, pp. 461–464 (2003).
51. 51 Markussen MDK, Heiberg A‐C, Nielsen R and Leirs H, Vitamin K requirement in Danish anticoagulant‐resistant Norway rats (Rattus norvegicus). Pest Manag Sci 59: 913–920 (2003).
52. 52 MacNicoll AD and Gill JE, Revised methodology for a blood‐clotting response test for identification of warfarin‐resistant Norway rats (Rattus norvegicus). Bull OEEP/EPPO Bull 23: 701–707 (1993).
53. 53 Prescott CV, A reappraisal of blood clotting response tests for anticoagulant resistance and a proposal for a standardised BCR test methodology, in Technical Monograph. CropLife International, Brussels, Belgium, p. 9 (2003).
54. 54 Livak KJ and Schmittgen TD, Analysis of relative gene expression data using real‐time quantitative PCR and the 2 −ΔΔ Ct method. Methods 25: 402–408 (2001).
55. 55 Kohn MH and Pelz H‐J, A gene‐anchored map position of the rat warfarin‐resistance locus, Rw, and its orthologs in mice and humans. Blood 96: 1996–1998 (2000).
56. 56 Mulder GJ, Sex differences in drug conjugation and their consequences for drug toxicity. Sulfation, glucuronidation and glutathinone conjugation. Chem Biol Interact 57: 1–15 (1986).
57. 57 Shapiro BH, Sexually dimorphic response of rat hepatic monooxygenases to low‐dose phenobarbital. Biochem Pharmacol 35: 1766–1768 (1986).
58. 58 Matschiner JT and Willingham AK, Influence of sex hormones on vitamin K deficiency and epoxidation of vitamin K in the rat. J Nutrition 104: 660–665 (1974).